Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time. For investigational use (in New Zealand) only.  GPX-DOX Embolic Device is under development and does not have marketing clearance or approval in any market at this time.

Continue ReadingInnovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery